Table of Contents

1 Study Coverage

• 1.1 Melatonin Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Melatonin Market Size Growth Rate by Product
  • 1.4.2 Pharmaceutical Grade
  • 1.4.3 Food Grade
• 1.5 Market by End User
  • 1.5.1 Global Melatonin Market Size Growth Rate by End User
  • 1.5.2 Dietary Supplements
  • 1.5.3 Medical
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Melatonin Market Size
  • 2.1.1 Global Melatonin Revenue 2014-2025
  • 2.1.2 Global Melatonin Sales 2014-2025
• 2.2 Melatonin Growth Rate by Regions
  • 2.2.1 Global Melatonin Sales by Regions
  • 2.2.2 Global Melatonin Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Melatonin Sales by Manufacturers
  • 3.1.1 Melatonin Sales by Manufacturers
  • 3.1.2 Melatonin Sales Market Share by Manufacturers
  • 3.1.3 Global Melatonin Market Concentration Ratio (CR5 and HHI)
• 3.2 Melatonin Revenue by Manufacturers
  • 3.2.1 Melatonin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Melatonin Revenue Share by Manufacturers (2014-2019)
• 3.3 Melatonin Price by Manufacturers
• 3.4 Melatonin Manufacturing Base Distribution, Product Types
  • 3.4.1 Melatonin Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Melatonin Product Type
  • 3.4.3 Date of International Manufacturers Enter into Melatonin Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Melatonin Sales by Product
• 4.2 Global Melatonin Revenue by Product
• 4.3 Melatonin Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Melatonin Breakdown Data by End User

6 North America

• 6.1 North America Melatonin by Countries
  • 6.1.1 North America Melatonin Sales by Countries
  • 6.1.2 North America Melatonin Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Melatonin by Product
• 6.3 North America Melatonin by End User

7 Europe

• 7.1 Europe Melatonin by Countries
  • 7.1.1 Europe Melatonin Sales by Countries
  • 7.1.2 Europe Melatonin Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Melatonin by Product
• 7.3 Europe Melatonin by End User

8 Asia Pacific

• 8.1 Asia Pacific Melatonin by Countries
  • 8.1.1 Asia Pacific Melatonin Sales by Countries
  • 8.1.2 Asia Pacific Melatonin Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Melatonin by Product
• 8.3 Asia Pacific Melatonin by End User

9 Central & South America

• 9.1 Central & South America Melatonin by Countries
  • 9.1.1 Central & South America Melatonin Sales by Countries
  • 9.1.2 Central & South America Melatonin Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Melatonin by Product
• 9.3 Central & South America Melatonin by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Melatonin by Countries
  • 10.1.1 Middle East and Africa Melatonin Sales by Countries
  • 10.1.2 Middle East and Africa Melatonin Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Melatonin by Product
• 10.3 Middle East and Africa Melatonin by End User

11 Company Profiles

• 11.1 Natrol
  • 11.1.1 Natrol Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Natrol Melatonin Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Natrol Melatonin Products Offered
  • 11.1.5 Natrol Recent Development
• 11.2 Pharmavite
  • 11.2.1 Pharmavite Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Pharmavite Melatonin Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Pharmavite Melatonin Products Offered
  • 11.2.5 Pharmavite Recent Development
• 11.3 Nature's Bounty
  • 11.3.1 Nature's Bounty Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Nature's Bounty Melatonin Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Nature's Bounty Melatonin Products Offered
  • 11.3.5 Nature's Bounty Recent Development
• 11.4 Jameison
  • 11.4.1 Jameison Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Jameison Melatonin Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Jameison Melatonin Products Offered
  • 11.4.5 Jameison Recent Development
• 11.5 Rexall Sundown
  • 11.5.1 Rexall Sundown Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Rexall Sundown Melatonin Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Rexall Sundown Melatonin Products Offered
  • 11.5.5 Rexall Sundown Recent Development
• 11.6 GNC
  • 11.6.1 GNC Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 GNC Melatonin Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 GNC Melatonin Products Offered
  • 11.6.5 GNC Recent Development
• 11.7 Xiu Zheng
  • 11.7.1 Xiu Zheng Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Xiu Zheng Melatonin Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Xiu Zheng Melatonin Products Offered
  • 11.7.5 Xiu Zheng Recent Development
• 11.8 Church & Dwight
  • 11.8.1 Church & Dwight Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Church & Dwight Melatonin Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Church & Dwight Melatonin Products Offered
  • 11.8.5 Church & Dwight Recent Development
• 11.9 By-Health
  • 11.9.1 By-Health Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 By-Health Melatonin Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 By-Health Melatonin Products Offered
  • 11.9.5 By-Health Recent Development
• 11.10 Pfizer
  • 11.10.1 Pfizer Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Pfizer Melatonin Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Pfizer Melatonin Products Offered
  • 11.10.5 Pfizer Recent Development
• 11.11 Solgar
• 11.12 Biotics Research
• 11.13 Now Food

12 Future Forecast

• 12.1 Melatonin Market Forecast by Regions
  • 12.1.1 Global Melatonin Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Melatonin Revenue Forecast by Regions 2019-2025
• 12.2 Melatonin Market Forecast by Product
  • 12.2.1 Global Melatonin Sales Forecast by Product 2019-2025
  • 12.2.2 Global Melatonin Revenue Forecast by Product 2019-2025
• 12.3 Melatonin Market Forecast by End User
• 12.4 North America Melatonin Forecast
• 12.5 Europe Melatonin Forecast
• 12.6 Asia Pacific Melatonin Forecast
• 12.7 Central & South America Melatonin Forecast
• 12.8 Middle East and Africa Melatonin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Melatonin Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Melatonin, also known as N-acetyl-5-methoxy tryptamine, is a hormone that is produced by the pineal gland in animals and regulates sleep and wakefulness. Melatonin is also produced in plants where it functions as a first line of defense against oxidative stress.
The classification of Melatonin includes Pharmaceutical Grade and Food Grade, and the proportion of Food Grade in 2016 is about 66%, and the proportion is in increasing trend from 2012 to 2016.
North America region is the largest supplier of Melatonin, with a production market share nearly 54% in 2016. Europe is the second largest supplier of Melatonin, enjoying production market share nearly 27% in 2016.
Market competition is not intense. Neurim Pharma, Natrol, Pharmavite, Nature's Bounty, Jameison, Rexall Sundown, GNC, Xiu Zheng, etc. are the leaders of the industry.
The global Melatonin market is valued at 700 million US$ in 2018 and will reach 2790 million US$ by the end of 2025, growing at a CAGR of 18.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Melatonin market based on company, product type, end user and key regions.

This report studies the global market size of Melatonin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Melatonin in these regions.
This research report categorizes the global Melatonin market by top players/brands, region, type and end user. This report also studies the global Melatonin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Natrol
Pharmavite
Nature's Bounty
Jameison
Rexall Sundown
GNC
Xiu Zheng
Church & Dwight
By-Health
Pfizer
Solgar
Biotics Research
Now Food

Market size by Product
Pharmaceutical Grade
Food Grade
Market size by End User
Dietary Supplements
Medical
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Melatonin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Melatonin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Melatonin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Melatonin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Melatonin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Melatonin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.